Ascending aortic aneurysm (AAA) is an uncommon but highly lethal condition (Clouse et al. 1998) . Most AAAs have unknown etiology and are classified as idiopathic (Kirsch et al. 2006) . In contrast to aneurysms of the descending aorta, AAAs are not commonly a result of atherosclerosis (Lilly et al. 1997) . Although the pathogenesis of AAAs remains unclear, the pathogenesis of aneurysmal disease appears to be associated with defects or deficiencies in structural proteins like elastin and collagen (Baxter et al. 1994) .
Collagen, in polymeric form, is a significant component of the media and the surrounding fibrous adventitia. Collagen is the most abundant structural protein within the aorta and provides much of the strength to the connective tissue involved in the arterial wall (Oxlund and Andreassen 1980) .
Prolidase is an enzyme that catalyzes the final step of collagen breakdown by liberating free proline for collagen recycling. It has been shown that the enzyme activity may be a step-limiting factor in the regulation of collagen biosynthesis (Palka and Phang 1997) . The enzyme plays a key role in the recycling of proline for collagen turnover and cell growth. Prolidase enzyme activity has been investigated in various disorders such as chronic liver disease, coronary artery disease (Myara et al. 1984; Yildiz et al. 2008) .
Although matrix metalloproteinases (MMPs) have been shown to play a role in the formation of aortic aneurysms, a relationship between serum prolidase activity and AAAs has not been previously studied (Fedak et al. 2003; Boyum et al. 2004; Ikonomidis et al. 2007) . Although prolidase is a cytosolic enzyme, the origin of serum prolidase activity was reported to be the liver and serum activity was correlated with the hepatic prolidase enzyme activity (Abraham et al. 2000) . We hypothesized that serum prolidase activity would vary with increasing aortic diameter. In the present study, we attempted to determine the circulat-ing serum prolidase activity in patients with aortic dilatation and compare those with controls.
Methods

Study population and echocardiographic examination
The study population included 80 consecutive patients referred for transthoracic echocardiography with the diagnosis of hypertension or chest pain between October 2008 and April 2009 to our institution. The patients were divided into two groups according to the ascending aortic diameter as those with aortic dilatation (> 3.7 cm, n = 60) and without aortic dilatation (control group ≤ 3.7 cm, n = 20). The patients with aortic dilatation were subdivided into two groups as the medium (ectasia) group (3.8-4.3 cm, n = 36) and large (aneurysmal) group (≥ 4.4 cm, n = 24) according to the literature (Stefanadis et al. 1989) . Past medical history and current medications were recorded, in addition to detailed physical examination and electrocardiographic evaluation in all cases. The ethical committee of Kartal Kosuyolu Yuksek Ihtisas Heart-Education and Research Hospital approved the study, and written consent was obtained from all patients.
The main exclusion criteria were the presence of clinical or laboratory evidence of congestive heart failure, atrial fibrillation, bicuspid aortic valve, aortic stenosis, pericardial disease, renal and hepatic dysfunction, hemolytic disorders, concomitant inflammatory diseases such as infections and autoimmune disorders, osteoporosis, recent major surgical procedure, previous stroke, previous myocardial infarction, documented coronary artery disease, chronic liver disease, connective tissue disease and neoplastic diseases. The medications that affect rate of collagen turnover (especially use of angiotensin converting enzyme inhibitors, angiotensin receptor blockers and aldosterone antagonist) were also excluded.
All participants underwent comprehensive two-dimensional, M-mode and Doppler echocardiographic examination performed by one experienced research echocardiographer blinded to the biochemical data; using commercially available echocardiograph equipped with 2.5-and 3.5-MHz transducer (Vivid System Five, GE Vingmed, Horten, Norway). Pulsed and color Doppler examinations were performed for determination of the presence and severity of aortic regurgitation. Aortic valve morphology was examined in parasternal longand short axis view. The ascending aortic diameter was measured at the level of proximal ascending aorta by M-mode tracings, under twodimensional control, in accordance with the American Society of Echocardiography guidelines, as the maximal distance between the two leading edges of the anterior and posterior aortic walls at end diastole (Sahn et al. 1978) . All measurements were repeated up to five times and averaged.
Blood sample collection
Blood samples were obtained after an overnight fasting and the serum was immediately separated from the cells by centrifugation at 3000 g for 10 min, stored at −80°C, and then analyzed. Since erythrocyte prolidase enzyme activity is relatively high, hemolyzed samples were discarded.
Measurement of serum prolidase activity
Briefly, 25 µ L of serum samples (prediluted with normal saline solution, 1:1, v:v), 75 µ L of incubation buffer containing 50 mM MnCl2H2O, and 30.7 mg/dL reduced glutathione (GSH) in 50 mM TrisHCl buffer (pH7.0) were mixed and incubated at 37°C for 30 min. Then 100 µ L of substrate solution (144 mM glycyl-L-proline in 50 mM Tris HCl buffer containing 50 mM MnCl2H2O) was added and waited at 37°C for 5 min. After the end of incubation 2.3 mL of modified Chinard reagent (1 mL of glacial acetic acid + 300 µ L of 50 mM Tris HCl buffer (pH 7.0) + 1 mL of ninhydrin solution (20 g/L ninhydrin in 0.5 M orthophosphoric acid)) was added into the reaction mixture. The mixture was then further incubated at 90°C for 30 min. After 1 mL of concentrated glacial acetic acid was added into the reaction mixture, absorbances of proline standards and samples were read at 515 nm wavelengths against sample blank in a spectrophotometer using reagent blank as zero. The unit of prolidase enzyme activity was determined as a capable enzyme amount to produce proline in 1 min. The supernatant was used for measurement of proline by the method proposed by Myara et al. (Myara et al. 1982) . Intra-assay coefficient of variation of the assay was 3.8%.
Statistical analysis
All analyses were conducted using SPSS 11.5 (SPSS Inc., Chicago, Illinois, USA). Continuous variables were expressed as mean ± S.D. and categorical variables were expressed as percentages. Crosstabs (χ 2 test) was performed to compare the relation between ordinal variables and comparison of continuous variables between the groups categorized according to ascending aortic diameter was performed using one-way analysis of variance (ANOVA) with least significant difference post-hoc test. The correlation between ascending aortic diameter and clinical characteristics and laboratory categorical and continuous variables was assessed by the Spearman and Pearson's correlation test, respectively. To determine independent predictors of the AAAs, multiple linear regression analysis was performed by including the parameters that were correlated with a P value of less than 0.05 in the Pearson's correlations. Standardized β regression coefficients and their significance from multiple linear regression analysis were reported. P value < 0.05 was considered statistically significant.
Results
Comparisons of clinical characteristics of the study population according to ascending aortic diameter
The study included 80 subjects grouped into three categories according to the ascending aortic diameter: control (≤ 3.7 cm, n = 20), medium (3.8-4.3 cm, n = 36), and large (≥ 4.4 cm, n = 24). The clinical characteristics, echocardiographic and laboratory parameters of the three groups are shown in Table 1 . The mean age and urea level were significantly higher in the two groups with aortic dilatation than in the control group (ANOVA p = 0.048 and p = 0.042 respectively). Serum prolidase activity was significantly higher in the control group (1386.3 ± 320.5 U/L) than in medium AAA group (1212.0 ± 282.5 U/L) and large AAA groups (1072.2 ± 192.3 U/L): for control group vs. medium group (P = 0.023) and large group (P < 0.001), respectively. Serum prolidase activity was marginally higher in the medium AAA group than in the large AAA group, but the difference was not statistically significant (P = 0.053) (Fig. 1) . There was graded decrease in mean serum prolidase activity with increasing aortic dimension (ANOVA P = 0.001).
Relationship between ascending aortic diameter and clinical characteristics and laboratory parameters
The relationship between the ascending aortic diameter and clinical characteristics and laboratory data is presented in Table 2 . Ascending aortic diameter was positively correlated with age and urea levels (P < 0.05 for both, Table 2 ). Additionally, ascending aorta diameter was inversely correlated with serum prolidase activity in bivariate analysis (P = 0.001, Table 2 ). To determine independent predictors of ascending aortic diameter, we then performed a stepwise linear regression analysis by including parameters that were significantly correlated with ascending aortic diameter. Serum prolidase activity (β = -0.44, P = 0.006) was the only independent predictor of aortic dilatation (Table 2 ).
Discussion
In our study, we have shown that patients with AAAs have lower serum prolidase activity compared to the patients without aortic dilatation. The patients with AAAs were older and had higher urea levels with normal creatinine levels. Of these three significantly different variables, multiple linear regression analysis revealed that only serum prolidase activity was an independent predictor for the pres- 0.8 ± 0.1 0.9 ± 0.2 0.9 ± 0.4 0.28 Hemoglobin (g/dl) 12.9 ± 1.6 13.5 ± 1.5 13.4 ± 1.5 0.44 WBC (/ml) 9407 ± 1450 6897 ± 2320 7764 ± 2160 0.31 Platelets (/µ ) 239.4 ± 63.5 261.9 ± 45.1 261.9 ± 37.1 0.31 Prolidase activity (U/l) 1386.3 ± 320.5* 1212.0 ± 282.5** 1072.2 ± 192.3 0.001 BMI, body mass index; LVEF, left ventricle ejection fraction; HDL, high-density lipoprotein; LDL, low-density lipoprotein; WBC, white blood cells; ANOVA, analysis of variance; *P = 0.023 versus medium, P < 0.001 versus large, **P = 0.053 versus large.
ence of AAAs. The patients with aortic aneurysms had similar frequency of hypertension, diabetes and smoking as the control group. In a previous study comparing hypertensive patients with and without aortic dilatation, age, gender and body mass index were found to be predictors of aortic dilatation (Cuspidi et al. 2006) . Our patient group with AAAs and the control group represent a low risk group with low incidence of hypertension, diabetes and smoking. Thus in the formation of AAAs, our analysis for other contributory factors that may end up in extracellular matrix alterations revealed serum prolidase levels as an independent factor. Extracellular matrix alterations are considered as a key element in the pathogenesis of aortic diseases, but there are different patterns. In abdominal aortic aneurysms, there are changes in collagen and massive elastic destruction, possibly caused by the action of inflammatory cell derived MMPs, whereas in AAAs, there is an accumulation of mucoid material (likely proteoglycans) and elastic fiber-delicate and localized fragmentation (Shah 1997) . Collagen is the most plentiful structural protein within the aorta and provides much of the strength to the connective tissue involved in the arterial wall (Oxlund and Andreassen 1980) . Two specific types of fibrillar collagen (Types I and III) provide tensile strength and help maintain the structural integrity of the vascular wall. As reported by Dobrin and Mrkvicka (1994) , collagen degradation is the ultimate cause of rupture. An imbalance between collagen degradation and its synthesis could therefore create the catabolic conditions that lead to rupture.
Prolidase, a cytosolic exopeptidase cleaving carboxyterminal proline and hydroxyproline of iminodipeptides, is recognized as an important regulator of endogenous protein synthesis, especially collagen, by providing endogenous proline. This recycled proline can then be used for further re-synthesis of collagen. Although prolidase activity was related to collagen metabolism, the mechanism and endpoints by which this enzyme is regulated remain unknown. Previously it has been shown that prolidase activity in normal fibroblasts is regulated by the interaction of extracellular matrix proteins, mainly type I collagen with b1 integrin receptor (Palka and Phang 1997) . Previous clinical studies have shown increased serum prolidase activity, which indicates increased collagen turnover, in chronic liver disease, coronary artery disease (Myara et al. 1984; Yildiz et al. 2008) . Conversely deficient/reduced serum prolidase activity was reported to be associated with lupus-like syndrome characterized by nonhealing skin ulcers owing to defective collagen turnover (Shrinath et al. 1997 ). Reduced serum prolidase activity was also reported in renal insufficiency as the kidney is the main source of prolidase (Evrenkaya et al. 2006; Liu et al. 2007 ). In recent years, Demirbag et al. showed that increased serum prolidase activity is associated with the presence hypertension independent of left ventricular hypertrophy (Demirbag et al. 2007 ). Our findings suggest that defective collagen re-synthesis that is mediated by decreased serum prolidase may play a role in the pathogenesis of AAAs, however this study is limited by the fact it relies on only laboratory data correlated with clinical findings. Another limitation of the study is that it relies on echocardiographic evaluation of the ascending aorta and data were not verified by computed tomography or magnetic resonance imaging. In conclusion this study shows that serum prolidase activity is significantly associated with the presence of AAAs; however the association of in vitro analysis with laboratory data are required to elucidate the exact mechanism by which prolidase may be operative in the pathogenesis of AAAs.
